NCT03729778 Impact of HIV-1 and Aging on Mucosal Vaccine Responses Status ACTIVE_NOT_RECRUITING Phase EARLY_PHASE1
NCT03729752 PET Imaging of Radiolabeled Anti-HIV-1 Envelope Monoclonal Antibody (VRC01) Status RECRUITING Phase PHASE1
NCT03719664 Albuvirtide and 3BNC117 as Long-Acting Maintenance Therapy in Virologically Suppressed Subjects Status UNKNOWN Phase PHASE2
NCT03709355 Pharmacokinetics Study to Evaluate Drug-Drug Interactions and Safety of Elpida® in Co-Administration With Other Drugs Status COMPLETED Phase PHASE1
NCT03706950 Post-approval Observational Study of Elpida® in the First Line Therapy for HIV-1 Infected Patients With Background Standard ART Status UNKNOWN Phase N/A
NCT03706924 Comparative Study of PK and BE of VM-1500FDC (Fixed-dose Combination) and Elpida® With Truvada® сo-administrated 1 Daily Fasting in Healthy Subjects Status COMPLETED Phase PHASE1
NCT03706911 Study to Evaluate Safety, Tolerability and Pharmacokinetics of VM-1500A-LAI Single and Multiple Ascending Doses in Healthy Subjects Status COMPLETED Phase PHASE1
NCT03706898 Study to Evaluate the Safety and PK of Elpida® in Healthy Subjects and Patients With Hepatic Impairment and to Assess the Impact of Food Intake and Drug-Drug Interactions With Other Antiviral Drugs Status COMPLETED Phase PHASE1
NCT03646370 Assessing Virologic Success and Metabolic Changes in Patients Switching From a TDF to TAF Containing Antiretroviral Therapy Regimen Status COMPLETED Phase N/A
NCT03624413 InTSHA: Interactive Transition Support for HIV-infected Adolescents Using Social Media Status COMPLETED Phase NA
NCT03589027 Darunavir and Rilpivirine Interactions With Levonorgestrel Implant Status UNKNOWN Phase PHASE2
NCT03580668 Effectiveness, Safety, Adherence, and Health-related Quality of Life in HIV-1 Infected Adults Receiving Bictegravir/ Emtricitabine/Tenofovir Alafenamide Status COMPLETED Phase N/A
NCT03570918 MGD014 in HIV-Infected Individuals on Suppressive Antiretroviral Therapy Status COMPLETED Phase PHASE1
NCT03567304 Neurocognitive Function Improvement After Switching From Efavirenz to Rilpivirine Status UNKNOWN Phase PHASE4